Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate

Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Struktur
1009117-94-5
CAS-Nr.
1009117-94-5
Englisch Name:
Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
Synonyma:
Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, stereoisomer;Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
CBNumber:
CB55495598
Summenformel:
C40H50N8O6
Molgewicht:
738.89
MOL-Datei:
1009117-94-5.mol

Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Eigenschaften

Siedepunkt:
1071.2±65.0 °C(Predicted)
Dichte
1.249±0.06 g/cm3(Predicted)
pka
10.92±0.46(Predicted)

Sicherheit

Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Daclatasvir RRSS Isomer is an isomer of?Daclatasvir (D101500), which is an inhibitor of?HCV protein NS5A and a?drug candidate for treating?hepatitis C (HCV).

Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 18018 56
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44843 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18865 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
hanfangpharma@126.com China 30968 58

  • Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
  • Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, stereoisomer
  • 1009117-94-5
Copyright 2019 © ChemicalBook. All rights reserved